Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

Influence of Gut Microbiota on Progression to Tuberculosis Generated by High Fat Diet-Induced Obesity in C3HeB/FeJ Mice.

Arias L, Goig GA, Cardona P, Torres-Puente M, Díaz J, Rosales Y, Garcia E, Tapia G, Comas I, Vilaplana C, Cardona PJ.

Front Immunol. 2019 Oct 18;10:2464. doi: 10.3389/fimmu.2019.02464. eCollection 2019.

2.

Correlation of blood biomarkers with early-onset seizures after an acute stroke event.

Abraira L, Giannini N, Santamarina E, Cazorla S, Bustamante A, Quintana M, Toledo M, Grau-López L, Jiménez M, Ciurans J, Becerra JL, Millán M, Cardona P, Terceño M, Zaragoza J, Cánovas D, Gasull T, Ustrell X, Rubiera M, Castellanos M, Dávalos A, Montaner J, Álvarez-Sabin J.

Epilepsy Behav. 2019 Oct 30:106549. doi: 10.1016/j.yebeh.2019.106549. [Epub ahead of print]

PMID:
31677998
3.

Regulatory T Cells in Mycobacterium tuberculosis Infection.

Cardona P, Cardona PJ.

Front Immunol. 2019 Sep 11;10:2139. doi: 10.3389/fimmu.2019.02139. eCollection 2019. Review.

4.

Clinical and neuroimaging criteria to improve the workflow in transfers for endovascular treatment evaluation.

Requena M, Olivé-Gadea M, Boned S, Ramos A, Cardona P, Urra X, Serena J, Silva Y, Purroy F, Ustrell X, Abilleira S, Tomasello A, Perez de la Ossa N, Molina CA, Ribo M, Rubiera M; Catalan Stroke Code and Reperfusion Consortium (Cat-SCR).

Int J Stroke. 2019 Sep 10:1747493019874725. doi: 10.1177/1747493019874725. [Epub ahead of print]

PMID:
31506026
5.

Novel Mechanisms of Valproate Hepatotoxicity: Impaired Mrp2 Trafficking and Hepatocyte Depolarization.

Fu D, Cardona P, Ho H, Watkins PB, Brouwer KLR.

Toxicol Sci. 2019 Jul 31. pii: kfz154. doi: 10.1093/toxsci/kfz154. [Epub ahead of print]

PMID:
31368504
6.

Transfer to the Local Stroke Center versus Direct Transfer to Endovascular Center of Acute Stroke Patients with Suspected Large Vessel Occlusion in the Catalan Territory (RACECAT): Study protocol of a cluster randomized within a cohort trial.

Abilleira S, Pérez de la Ossa N, Jiménez X, Cardona P, Cocho D, Purroy F, Serena J, Román LS, Urra X, Vilaró M, Cortés J, González JA, Chamorro Á, Gallofré M, Jovin T, Molina C, Cobo E, Dávalos A, Ribó M.

Int J Stroke. 2019 Oct;14(7):734-744. doi: 10.1177/1747493019852176. Epub 2019 May 29.

PMID:
31142219
7.

RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice.

Prabowo SA, Painter H, Zelmer A, Smith SG, Seifert K, Amat M, Cardona PJ, Fletcher HA.

Front Immunol. 2019 Apr 30;10:894. doi: 10.3389/fimmu.2019.00894. eCollection 2019.

8.

How Far Are we Away From an Improved Vaccine For Tuberculosis? Current Efforts and Future Prospects.

Vilaplana C, Cardona PJ.

Arch Bronconeumol. 2019 Jul;55(7):373-377. doi: 10.1016/j.arbres.2018.11.002. Epub 2018 Dec 26. Review. English, Spanish.

9.

Revalidation of the RACE scale after its regional implementation in Catalonia: a triage tool for large vessel occlusion.

Carrera D, Gorchs M, Querol M, Abilleira S, Ribó M, Millán M, Ramos A, Cardona P, Urra X, Rodríguez-Campello A, Prats-Sánchez L, Purroy F, Serena J, Cánovas D, Zaragoza-Brunet J, Krupinski JA, Ustrell X, Saura J, García S, Mora MÀ, Jiménez X, Dávalos A, Pérez de la Ossa N; Catalan Stroke Code and Reperfusion Consortium (Cat-SCR).

J Neurointerv Surg. 2019 Aug;11(8):751-756. doi: 10.1136/neurintsurg-2018-014519. Epub 2018 Dec 22.

PMID:
30580284
10.

Anaphylaxis Due to Poloxamer 238.

Carbonell A, Escudero AI, Miralles JC, González A, Navarro C, Cardona P, Jimeno L, Pineda F.

J Investig Allergol Clin Immunol. 2018 Dec;28(6):419-420. doi: 10.18176/jiaci.0298. No abstract available.

11.

Predictors of Endovascular Treatment Among Stroke Codes Activated Within 6 Hours From Symptom Onset.

Requena M, Pérez de la Ossa N, Abilleira S, Cardona P, Urra X, Martí-Fabregas J, Rodríguez-Campello A, Boned S, Rubiera M, Tomasello A, Molina CA, Ribo M; for Catalan Stroke Code and Reperfusion Consortium.

Stroke. 2018 Sep;49(9):2116-2121. doi: 10.1161/STROKEAHA.118.021316.

PMID:
30354973
12.

The neurologist's approach to cerebral infarct and transient ischaemic attack in patients receiving anticoagulant treatment for non-valvular atrial fibrillation: ANITA-FA study.

Zapata-Wainberg G, Masjuan J, Quintas S, Ximénez-Carrillo Á, García Pastor A, Martínez Zabaleta M, Cardona P, Freijo Guerrero MM, Llull L, Benavente Fernández L, Castellanos Rodrigo M, Egido J, Serena J, Vivancos J; researchers in the ANITA-FA study.

Eur J Neurol. 2019 Feb;26(2):230-237. doi: 10.1111/ene.13792. Epub 2018 Sep 24.

PMID:
30153363
13.

Telestroke in Catalonia: Increasing Thrombolysis Rate and Avoiding Interhospital Transfers.

López-Cancio E, Ribó M, Cardona P, Serena J, Purroy F, Palomeras E, Aragonès JM, Cocho D, Garcés M, Puiggròs E, Soteras I, Cabanelas A, Villagrasa D, Catena E, Sanjurjo E, López Claverol N, Carrión D, López M, Abilleira S, Dávalos A, Pérez de la Ossa N; Catalan Stroke Code and Reperfusion Consortium (Cat-SCR).

Cerebrovasc Dis. 2018;46(1-2):66-71. doi: 10.1159/000492124. Epub 2018 Aug 22.

PMID:
30134222
14.

The burden of disease in Spain: Results from the Global Burden of Disease 2016.

Soriano JB, Rojas-Rueda D, Alonso J, Antó JM, Cardona PJ, Fernández E, Garcia-Basteiro AL, Benavides FG, Glenn SD, Krish V, Lazarus JV, Martínez-Raga J, Masana MF, Nieuwenhuijsen MJ, Ortiz A, Sánchez-Niño MD, Serrano-Blanco A, Tortajada-Girbés M, Tyrovolas S, Haro JM, Naghavi M, Murray CJL; Colaboradores de GBD en España; Lista de colaboradores de GBD en España:.

Med Clin (Barc). 2018 Sep 14;151(5):171-190. doi: 10.1016/j.medcli.2018.05.011. Epub 2018 Jul 20. English, Spanish.

15.

Factors associated with poor anticoagulation control with vitaminK antagonists among outpatients attended in Internal Medicine and Neurology. The ALADIN study.

Contreras Muruaga MM, Reig G, Vivancos J, González A, Cardona P, Ramírez-Moreno JM, Martí-Fábregas J, Suárez Fernández C; en nombre de los investigadores del estudio ALADIN; Listado de investigadores del estudio ALADIN.

Rev Clin Esp. 2018 Oct;218(7):327-335. doi: 10.1016/j.rce.2018.04.020. Epub 2018 Jul 6. English, Spanish.

PMID:
29983190
16.

Epidemiology of Intracranial Hemorrhage Associated with Oral Anticoagulants in Spain: Trends in Anticoagulation Complications Registry - The TAC 2 Study.

Zapata-Wainberg G, Quintas S, Ximénez-Carrillo Rico Á, Masjuán Vallejo J, Cardona P, Castellanos Rodrigo M, Benavente Fernández L, García Pastor A, Egido J, Maciñeiras J, Serena J, Freijo Guerrero MDM, Moniche F, Vivancos J.

Interv Neurol. 2018 Apr;7(5):284-295. doi: 10.1159/000487518. Epub 2018 Apr 4.

17.

A Beneficial Effect of Low-Dose Aspirin in a Murine Model of Active Tuberculosis.

Kroesen VM, Rodríguez-Martínez P, García E, Rosales Y, Díaz J, Martín-Céspedes M, Tapia G, Sarrias MR, Cardona PJ, Vilaplana C.

Front Immunol. 2018 Apr 23;9:798. doi: 10.3389/fimmu.2018.00798. eCollection 2018.

18.

A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis.

Leung-Theung-Long S, Coupet CA, Gouanvic M, Schmitt D, Ray A, Hoffmann C, Schultz H, Tyagi S, Soni H, Converse PJ, Arias L, Kleinpeter P, Sansas B, Mdluli K, Vilaplana C, Cardona PJ, Nuermberger E, Marchand JB, Silvestre N, Inchauspé G.

PLoS One. 2018 May 2;13(5):e0196815. doi: 10.1371/journal.pone.0196815. eCollection 2018.

19.

Mechanical Thrombectomy for Patients With Infective Endocarditis and Ischemic Large-Vessel Stroke.

Cuervo G, Caballero Q, Rombauts A, Grau I, Ardanuy C, Cardona P, Carratalà J.

Clin Infect Dis. 2018 Sep 14;67(7):1145-1146. doi: 10.1093/cid/ciy272. No abstract available.

PMID:
29659755
20.

High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection against Tuberculosis.

Billeskov R, Lindenstrøm T, Woodworth J, Vilaplana C, Cardona PJ, Cassidy JP, Mortensen R, Agger EM, Andersen P.

Front Immunol. 2018 Jan 15;8:1973. doi: 10.3389/fimmu.2017.01973. eCollection 2017.

21.

Pathogenesis of tuberculosis and other mycobacteriosis.

Cardona PJ.

Enferm Infecc Microbiol Clin. 2018 Jan;36(1):38-46. doi: 10.1016/j.eimc.2017.10.015. Epub 2017 Dec 2. English, Spanish.

PMID:
29198784
22.

Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct.

Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, Yavagal DR, Ribo M, Cognard C, Hanel RA, Sila CA, Hassan AE, Millan M, Levy EI, Mitchell P, Chen M, English JD, Shah QA, Silver FL, Pereira VM, Mehta BP, Baxter BW, Abraham MG, Cardona P, Veznedaroglu E, Hellinger FR, Feng L, Kirmani JF, Lopes DK, Jankowitz BT, Frankel MR, Costalat V, Vora NA, Yoo AJ, Malik AM, Furlan AJ, Rubiera M, Aghaebrahim A, Olivot JM, Tekle WG, Shields R, Graves T, Lewis RJ, Smith WS, Liebeskind DS, Saver JL, Jovin TG; DAWN Trial Investigators.

N Engl J Med. 2018 Jan 4;378(1):11-21. doi: 10.1056/NEJMoa1706442. Epub 2017 Nov 11.

23.

Fixed Eruption by Multiple Plant Foods.

Carbonell A, Miralles JC, Escudero AI, Cardona P, González A, Navarro C.

J Investig Allergol Clin Immunol. 2017;27(5):324-325. doi: 10.18176/jiaci.0176. No abstract available.

24.

[Clinical profile and satisfaction with anticoagulated treatment in patients with non-valvular atrial fibrillation attended in Internal Medicine and Neurology departments of Spain].

Reig-Rosello G, Contreras MM, Suarez-Fernandez C, Gonzalez-Hernandez A, Cardona P, Pons-Amate JM, Marti-Fabregas J, Vivancos J.

Rev Neurol. 2017 Oct 16;65(8):361-367. Spanish.

25.

Cost-effectiveness of mechanical thrombectomy using stent retriever after intravenous tissue plasminogen activator compared with intravenous tissue plasminogen activator alone in the treatment of acute ischaemic stroke due to large vessel occlusion in Spain.

de Andrés-Nogales F, Álvarez M, de Miquel MÁ, Segura T, Gil A, Cardona P, Casado MÁ, Nogueira RG, Dávalos A.

Eur Stroke J. 2017 Sep;2(3):272-284. doi: 10.1177/2396987317721865. Epub 2017 Aug 1.

26.

Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study.

Bustamante A, López-Cancio E, Pich S, Penalba A, Giralt D, García-Berrocoso T, Ferrer-Costa C, Gasull T, Hernández-Pérez M, Millan M, Rubiera M, Cardona P, Cano L, Quesada H, Terceño M, Silva Y, Castellanos M, Garces M, Reverté S, Ustrell X, Marés R, Baiges JJ, Serena J, Rubio F, Salas E, Dávalos A, Montaner J.

Stroke. 2017 Sep;48(9):2419-2425. doi: 10.1161/STROKEAHA.117.017076. Epub 2017 Jul 17.

PMID:
28716979
27.

Influence of Hospital Type on Outcomes of Individuals Aged 80 and Older with Stroke Treated Using Intravenous Thrombolysis.

Purroy F, Vena A, Cánovas D, Cardona P, Cocho D, Cuadrado-Godia E, Chamorro A, Dávalos A, Garcés M, Gomis M, Krupinski J, Palomeras E, Ribó M, Roquer J, Rubiera M, Sanahuja J, Saura J, Serena J, Ustrell X, Vargas M, Benabdelhak I, Abilleira S, Gallofré M; Catalan Stroke Code and Reperfusion Consortium.

J Am Geriatr Soc. 2017 Sep;65(9):E117-E122. doi: 10.1111/jgs.14935. Epub 2017 Jun 2.

PMID:
28574595
28.

Cross-situational word learning in aphasia.

Peñaloza C, Mirman D, Cardona P, Juncadella M, Martin N, Laine M, Rodríguez-Fornells A.

Cortex. 2017 Aug;93:12-27. doi: 10.1016/j.cortex.2017.04.020. Epub 2017 May 4.

PMID:
28570928
29.

Geographic dissemination of endovascular stroke thrombectomy in Catalonia within the 2011-2015 period.

Abilleira S, Tebé C, de la Ossa NP, Ribó M, Cardona P, Urra X, Giralt-Steinhauer E, Cánovas D, Camps-Renom P, Gallofré M; Cat-SCR Consortium.

Eur Stroke J. 2017 Jun;2(2):163-170. doi: 10.1177/2396987317696376. Epub 2017 Feb 27.

30.

What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the "Pink Swan".

Cardona PJ.

Front Immunol. 2017 May 15;8:556. doi: 10.3389/fimmu.2017.00556. eCollection 2017. Review.

31.

Satisfaction, quality of life and perception of patients regarding burdens and benefits of vitamin K antagonists compared with direct oral anticoagulants in patients with nonvalvular atrial fibrillation.

Contreras Muruaga MDM, Vivancos J, Reig G, González A, Cardona P, Ramírez-Moreno JM, Martí J, Suárez Fernández C; ALADIN Study Investigators.

J Comp Eff Res. 2017 Jun;6(4):303-312. doi: 10.2217/cer-2016-0078. Epub 2017 Mar 29.

PMID:
28353372
32.

Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial.

Dávalos A, Cobo E, Molina CA, Chamorro A, de Miquel MA, Román LS, Serena J, López-Cancio E, Ribó M, Millán M, Urra X, Cardona P, Tomasello A, Castaño C, Blasco J, Aja L, Rubiera M, Gomis M, Renú A, Lara B, Martí-Fàbregas J, Jankowitz B, Cerdà N, Jovin TG; REVASCAT Trial Investigators.

Lancet Neurol. 2017 May;16(5):369-376. doi: 10.1016/S1474-4422(17)30047-9. Epub 2017 Mar 16.

PMID:
28318984
33.

Vessel Patency at 24 Hours and Its Relationship With Clinical Outcomes and Infarct Volume in REVASCAT Trial (Randomized Trial of Revascularization With Solitaire FR Device Versus Best Medical Therapy in the Treatment of Acute Stroke Due to Anterior Circulation Large Vessel Occlusion Presenting Within Eight Hours of Symptom Onset).

Millán M, Remollo S, Quesada H, Renú A, Tomasello A, Minhas P, Pérez de la Ossa N, Rubiera M, Llull L, Cardona P, Al-Ajlan F, Hernández M, Assis Z, Demchuk AM, Jovin T, Dávalos A; REVASCAT Trial Investigators.

Stroke. 2017 Apr;48(4):983-989. doi: 10.1161/STROKEAHA.116.015455. Epub 2017 Mar 14.

PMID:
28292867
34.

Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae® in adults with or without latent TB infection: Safety and immunogenicity.

Montané E, Barriocanal AM, Arellano AL, Valderrama A, Sanz Y, Perez-Alvarez N, Cardona P, Vilaplana C, Cardona PJ.

PLoS One. 2017 Feb 9;12(2):e0171294. doi: 10.1371/journal.pone.0171294. eCollection 2017.

35.

Experimental animal modelling for TB vaccine development.

Cardona PJ, Williams A.

Int J Infect Dis. 2017 Mar;56:268-273. doi: 10.1016/j.ijid.2017.01.030. Epub 2017 Feb 3. Review.

36.

Proteoliposomal formulations of an HIV-1 gp41-based miniprotein elicit a lipid-dependent immunodominant response overlapping the 2F5 binding motif.

Molinos-Albert LM, Bilbao E, Agulló L, Marfil S, García E, Rodríguez de la Concepción ML, Izquierdo-Useros N, Vilaplana C, Nieto-Garai JA, Contreras FX, Floor M, Cardona PJ, Martinez-Picado J, Clotet B, Villà-Freixa J, Lorizate M, Carrillo J, Blanco J.

Sci Rep. 2017 Jan 13;7:40800. doi: 10.1038/srep40800.

37.

Outcomes After Direct Thrombectomy or Combined Intravenous and Endovascular Treatment Are Not Different.

Abilleira S, Ribera A, Cardona P, Rubiera M, López-Cancio E, Amaro S, Rodríguez-Campello A, Camps-Renom P, Cánovas D, de Miquel MA, Tomasello A, Remollo S, López-Rueda A, Vivas E, Perendreu J, Gallofré M; Catalan Stroke Code and Reperfusion Consortium.

Stroke. 2017 Feb;48(2):375-378. doi: 10.1161/STROKEAHA.116.015857. Epub 2017 Jan 6.

PMID:
28062859
38.

Development of the food supplement Nyaditum resae as a new tool to reduce the risk of tuberculosis development.

Tukvadze N, Cardona P, Vashakidze S, Shubladze N, Avaliani Z, Vilaplana C, Cardona PJ.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S101-S102. doi: 10.1016/j.ijmyco.2016.09.073. Epub 2016 Nov 14.

39.

Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in Georgia.

Vashakidze S, Despuig A, Gogishvili S, Nikolaishvili K, Shubladze N, Avaliani Z, Tukvadze N, Casals M, Caylà JA, Cardona PJ, Vilaplana C.

Int J Infect Dis. 2017 Mar;56:200-207. doi: 10.1016/j.ijid.2016.12.009. Epub 2016 Dec 19. Review.

40.

Endovascular treatment improves cognition after stroke: A secondary analysis of REVASCAT trial.

López-Cancio E, Jovin TG, Cobo E, Cerdá N, Jiménez M, Gomis M, Hernández-Pérez M, Cáceres C, Cardona P, Lara B, Renú A, Llull L, Boned S, Muchada M, Dávalos A.

Neurology. 2017 Jan 17;88(3):245-251. doi: 10.1212/WNL.0000000000003517. Epub 2016 Dec 9.

41.

Reactivation or reinfection in adult tuberculosis: Is that the question?

Cardona PJ.

Int J Mycobacteriol. 2016 Dec;5(4):400-407. doi: 10.1016/j.ijmyco.2016.09.017. Epub 2016 Oct 27. Review.

42.

The Progress of Therapeutic Vaccination with Regard to Tuberculosis.

Cardona PJ.

Front Microbiol. 2016 Sep 28;7:1536. eCollection 2016. Review.

43.

Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis.

Saver JL, Goyal M, van der Lugt A, Menon BK, Majoie CB, Dippel DW, Campbell BC, Nogueira RG, Demchuk AM, Tomasello A, Cardona P, Devlin TG, Frei DF, du Mesnil de Rochemont R, Berkhemer OA, Jovin TG, Siddiqui AH, van Zwam WH, Davis SM, Castaño C, Sapkota BL, Fransen PS, Molina C, van Oostenbrugge RJ, Chamorro Á, Lingsma H, Silver FL, Donnan GA, Shuaib A, Brown S, Stouch B, Mitchell PJ, Davalos A, Roos YB, Hill MD; HERMES Collaborators.

JAMA. 2016 Sep 27;316(12):1279-88. doi: 10.1001/jama.2016.13647.

PMID:
27673305
44.

Novel word acquisition in aphasia: Facing the word-referent ambiguity of natural language learning contexts.

Peñaloza C, Mirman D, Tuomiranta L, Benetello A, Heikius IM, Järvinen S, Majos MC, Cardona P, Juncadella M, Laine M, Martin N, Rodríguez-Fornells A.

Cortex. 2016 Jun;79:14-31. doi: 10.1016/j.cortex.2016.03.009. Epub 2016 Mar 19.

46.

Access to Endovascular Treatment in Remote Areas: Analysis of the Reperfusion Treatment Registry of Catalonia.

Pérez de la Ossa N, Abilleira S, Dorado L, Urra X, Ribó M, Cardona P, Giralt E, Martí-Fàbregas J, Purroy F, Serena J, Cánovas D, Garcés M, Krupinski J, Pellisé A, Saura J, Molina C, Dávalos A, Gallofré M; Catalan Stroke Code and Reperfusion Consortium.

Stroke. 2016 May;47(5):1381-4. doi: 10.1161/STROKEAHA.116.013069. Epub 2016 Mar 31.

PMID:
27032445
47.

Local Inflammation, Dissemination and Coalescence of Lesions Are Key for the Progression toward Active Tuberculosis: The Bubble Model.

Prats C, Vilaplana C, Valls J, Marzo E, Cardona PJ, López D.

Front Microbiol. 2016 Feb 2;7:33. doi: 10.3389/fmicb.2016.00033. eCollection 2016.

48.

Individual-Based Modeling of Tuberculosis in a User-Friendly Interface: Understanding the Epidemiological Role of Population Heterogeneity in a City.

Prats C, Montañola-Sales C, Gilabert-Navarro JF, Valls J, Casanovas-Garcia J, Vilaplana C, Cardona PJ, López D.

Front Microbiol. 2016 Jan 12;6:1564. doi: 10.3389/fmicb.2015.01564. eCollection 2015.

49.

Oral Administration of Heat-Killed Mycobacterium manresensis Delays Progression toward Active Tuberculosis in C3HeB/FeJ Mice.

Cardona P, Marzo-Escartín E, Tapia G, Díaz J, García V, Varela I, Vilaplana C, Cardona PJ.

Front Microbiol. 2016 Jan 5;6:1482. doi: 10.3389/fmicb.2015.01482. eCollection 2015.

50.

Mechanical Thrombectomy in and Outside the REVASCAT Trial: Insights From a Concurrent Population-Based Stroke Registry.

Urra X, Abilleira S, Dorado L, Ribó M, Cardona P, Millán M, Chamorro A, Molina C, Cobo E, Dávalos A, Jovin TG, Gallofré M; Catalan Stroke Code and Reperfusion Consortium.

Stroke. 2015 Dec;46(12):3437-42. doi: 10.1161/STROKEAHA.115.011050. Epub 2015 Oct 27.

PMID:
26508752

Supplemental Content

Loading ...
Support Center